GUJARAT KIDNEY N SUP SP L (GKSL) Share Price Rises 9% Today

GUJARAT KIDNEY N SUP SP L rose to Rs 148.95, up 9% today, taking its market capitalisation to Rs 1,077.

GUJARAT KIDNEY N SUP SP L Share Price moved up to Rs 148.95 on 17 August 2026, a gain of 9% from the previous close of Rs 136.65, lifting the company’s market capitalisation to Rs 1,077.39 crore.

For investors tracking GUJARAT KIDNEY N SUP SP L Share Price Today, the verified data confirms a meaningful same-day price rise rather than a longer-term milestone. The stock opened at Rs 136.7, traded between Rs 133.4 and Rs 149.75, and reached turnover of Rs 4.3 crore. Total traded volume stood at 11,87,596 shares, with 2,88,831 shares on BSE and 8,98,765 shares on NSE, showing broad market participation across exchanges even though the supplied primary volume exchange is BSE.

As part of Univest coverage of Stocks in News and Top Gainers Today, the data establishes what happened in the market, but it does not establish a company-specific catalyst for why the stock is rising today. What it does show is that GUJARAT KIDNEY N SUP SP L Share Price has attracted attention through price action, valuation metrics, profitability ratios and its position within the Healthcare sector’s Hospital & Healthcare Services industry. That makes this a useful Stock News and stock analysis case for investors who want to understand today’s rally in context.

GUJARAT KIDNEY N SUP SP L (GKSL) Share Price Today: Price Action Analysis

GUJARAT KIDNEY N SUP SP L (GKSL) traded at Rs 148.95. versus the previous close of Rs 136.65, a rise of 9%. The stock opened at Rs 136.7, reached Rs 149.75, touched Rs 133.4. Reported volume was 2,88,831.

GUJARAT KIDNEY N SUP SP L (GKSL) Fundamental Analysis

GUJARAT KIDNEY N SUP SP L was valued at a P/E ratio of 68.04x, a P/B ratio of 4.27x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 26.56% and ROCE of 36.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 2.01, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

GUJARAT KIDNEY N SUP SP L Fundamental Analysis shows a mix of elevated valuation and solid profitability metrics. With a market capitalisation of Rs 1,077.39 crore, the company sits in the small-cap bracket by size, but that alone does not define quality. The valuation multiples offer the first important layer of context: the stock trades at a P/E ratio of 68.04 and a P/B ratio of 4.27.

For investors reading GUJARAT KIDNEY N SUP SP L Stock News and GUJARAT KIDNEY N SUP SP L Financial Results context through market ratios, the company’s profitability profile is stronger than a simple small-cap label might suggest. Return on equity stands at 26.56%, while return on capital employed is 36.31%. These are meaningful operating and capital-efficiency numbers because ROE measures returns generated on shareholder equity and ROCE measures returns generated on capital employed across the business.

EPS is Rs 2.01, which indicates the earnings attributable to each share based on the supplied data. Dividend yield is 0, which means the current historical payout yield contribution to total shareholder return is absent at this price point. In practical terms, the present investor case in GUJARAT KIDNEY N SUP SP L Share Price is more tied to earnings valuation and operating returns than to income distribution.

The combination of P/E at 68.04 and P/B at 4.27 means the stock is not cheaply valued in absolute terms. However, those multiples need to be read alongside ROE of 26.56% and ROCE of 36.31%, because stronger returns can sometimes support richer market multiples. Univest therefore sees a stock where valuation is demanding relative to many businesses, but profitability metrics are also robust enough to explain why investors may be paying close attention after the latest price rise.

That said, GUJARAT KIDNEY N SUP SP L Share Price is best understood not in isolation but against the sector benchmark and listed peers in Hospital & Healthcare Services, which is the next crucial layer of analysis.

Sector and Industry Context

GUJARAT KIDNEY N SUP SP L (GKSL) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

GUJARAT KIDNEY N SUP SP L (GKSL) has a P/E ratio of 68.04x, which is above the benchmark median of 32.08x, a difference of +112.09%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

GUJARAT KIDNEY N SUP SP L (GKSL) has a ROE of 26.56%, which is above the benchmark median of 13.45%, a difference of +97.47%. GUJARAT KIDNEY N SUP SP L (GKSL) has a ROCE of 36.31%, which is above the benchmark median of 17.15%, a difference of +111.72%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The Healthcare sector and Hospital & Healthcare Services industry data provide a strong benchmark for interpreting this move. GUJARAT KIDNEY N SUP SP L operates in an industry set where its valuation and profitability can be compared with 42 same-industry companies, making today’s share price rise easier to frame against direct benchmarks.

The supplied sector snapshot uses the same industry as the benchmark scope and covers 42 companies. Within that group, GUJARAT KIDNEY N SUP SP L has a company P/E of 68.04. That is above the industry median P/E of 32.08, but below the industry average P/E of 117.35. It also sits within a very wide industry P/E range of 8.63 to 1,603.4 across 34 companies with available P/E data. In plain terms, GUJARAT KIDNEY N SUP SP L Share Price carries a valuation premium to the median peer, though not to the industry average.

On P/B, the company is at 4.27 versus a median of 2 and an average of 1.85 across 42 companies. That places the stock above both benchmark measures on book-value valuation. For investors searching GUJARAT KIDNEY N SUP SP L Share Price Rise and sector analysis, this suggests the market is assigning a higher multiple to the company’s equity base than it does for the typical industry constituent.

Profitability offers a more supportive comparison. Company ROE is 26.56%, above the benchmark median of 13.45% but below the benchmark average of 34.25%. Company ROCE is 36.31%, well above both the benchmark median of 17.15% and average of 20.39%. Market-cap context is also relevant: at Rs 1,077.39 crore, the company is far above the industry median market capitalisation of Rs 91.41 crore and above the industry average of Rs 436.48 crore, though still below the industry maximum of Rs 2,612.26 crore. Univest reads this as a company with above-median scale and clearly above-median capital efficiency, but with valuation multiples that already reflect some of that strength.

Peer Comparison

GUJARAT KIDNEY N SUP SP L (GKSL) has a P/E ratio of 68.04x compared with the displayed peer median of 38.83x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 26.56% compares with a peer median of 5.19% across the companies shown in the table. ROCE stood at 36.31% versus the displayed peer median of 22.94%, providing a capital-efficiency comparison. GUJARAT KIDNEY N SUP SP L (GKSL) has a market capitalisation of Rs 1,077.39 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

The peer set shows GUJARAT KIDNEY N SUP SP L sitting in the middle of the sector by market capitalisation, while trading at a richer valuation than several named healthcare peers. The relative comparison is important because it helps distinguish whether today’s move is occurring in a deeply discounted stock or one already carrying premium expectations.

At Rs 1,077.39 crore in market capitalisation, the company is close to Unihealth Hospitals Ltd. at Rs 1,075.08 crore and below GPT Healthcare Ltd. at Rs 1,280.06 crore, SURAKSHA DIAGNOSTIC LIMITED at Rs 1,583.26 crore and Shalby Ltd. at Rs 1,658.49 crore. It is also well below Dr Agarwals Eye Hospital Ltd. at Rs 2,612.26 crore and KMC Speciality Hospitals (India) Ltd. at Rs 2,165.77 crore. That places it in a meaningful but not dominant position among listed peers.

On valuation, GUJARAT KIDNEY N SUP SP L trades at 68.04 times earnings, which is materially above Dr Agarwals Eye Hospital at 34.27, KMC Speciality Hospitals at 38.83, Krsnaa Diagnostics at 19.18, Shalby at 42.19, SURAKSHA at 44.23, GPT Healthcare at 27.08, Unihealth Hospitals at 41.62, GAUDIUM IVF N WOMEN H L at 36.69 and CHANDAN HEALTHCARE LTD at 22.41. This makes the stock one of the higher-P/E names in the supplied comparison set.

P/B at 4.27 is lower than several premium-book peers such as KMC Speciality Hospitals at 9.54, Unihealth Hospitals at 7.73, Dr Agarwals Eye Hospital at 7.07, SURAKSHA at 6.14 and GAUDIUM IVF N WOMEN H L at 5.82, but above Krsnaa Diagnostics at 1.87, Shalby at 1.63 and CHANDAN HEALTHCARE LTD at 3.57. Profitability is competitive: ROE at 26.56% is above KMC’s 22.42%, SURAKSHA’s 13.93% and Shalby’s 5.19%, though below GPT Healthcare’s 33.06%, Unihealth’s 29.75% and especially GAUDIUM IVF’s 94.99%. ROCE at 36.31% is stronger than many peers, including KMC at 25.85%, SURAKSHA at 22.94%, GPT Healthcare at 25.56% and Unihealth at 20.33%, though below Krsnaa Diagnostics at 129.09% and GAUDIUM IVF at 82.39%. Univest therefore sees a stock with standout capital efficiency, but one whose P/E already prices in a meaningful amount of optimism versus peers.

Why Investors Are Watching GUJARAT KIDNEY N SUP SP L

Investors are watching this stock because the price action, market-cap category trigger and sector-relative fundamentals all create a clear event-driven setup.

• Verified price action: the stock rose 9% to Rs 148.95 from Rs 136.65 and traded in a broad range of Rs 133.4 to Rs 149.75.
• Trading activity: turnover reached Rs 4.3 crore and total traded volume stood at 11,87,596 shares across BSE and NSE.
• Fundamental context: P/E is 68.04, P/B is 4.27, ROE is 26.56% and ROCE is 36.31%.
• Sector positioning: P/E is above the industry median of 32.08, while ROCE is above the industry average of 20.39%.
• Peer setup: market cap is close to Unihealth Hospitals, but P/E is higher than all listed peers in the supplied comparison set.

What investors may monitor next is whether GUJARAT KIDNEY N SUP SP L Share Price can sustain interest at a valuation that is above the median industry multiple, while continuing to justify attention through its profitability profile and market activity. Univest coverage suggests that the key issue is not just the price rise itself, but whether the stock’s premium metrics remain supported relative to sector and peer benchmarks.

About GUJARAT KIDNEY N SUP SP L

GUJARAT KIDNEY N SUP SP L is classified within the Healthcare sector and the Hospital & Healthcare Services industry. Even without broader descriptive inputs, this classification is useful because it places the company inside a business segment where investors typically track service-led healthcare demand, operating efficiency and valuation multiples relative to listed hospital and diagnostic peers.

The company’s current market position, based on the supplied numbers, is that of a small-cap healthcare name with market capitalisation of Rs 1,077.39 crore. Within the same-industry benchmark of 42 companies, that size is above the median market capitalisation of Rs 91.41 crore and the average of Rs 436.48 crore. That suggests the company occupies a larger-than-typical listed position within its industry set, even though it remains below the biggest peer in the sample.

Its peer grouping includes hospitals, diagnostics and related healthcare service companies such as Dr Agarwals Eye Hospital, KMC Speciality Hospitals, Krsnaa Diagnostics, Shalby, SURAKSHA DIAGNOSTIC, GPT Healthcare and Unihealth Hospitals. In this operating context, GUJARAT KIDNEY N SUP SP L Share Price is being assessed not only as a trading move for Share Market Today, but also as part of a wider healthcare-services comparison built around valuation, return ratios and relative scale. That gives investors a practical framework for reading the stock’s latest Market Update through industry numbers rather than in isolation.

Track GUJARAT KIDNEY N SUP SP L Share Price on Univest

Use GUJARAT KIDNEY N SUP SP L (GKSL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers who want to follow GUJARAT KIDNEY N SUP SP L Share Price on an ongoing basis can use Univest to monitor live share price moves, market capitalisation, valuation ratios, profitability indicators and broader stock performance context. Univest also helps users track 52-week levels, sector positioning, peer comparison and day-by-day Stock Updates in one place.

For investors following GUJARAT KIDNEY N SUP SP L Latest News, GUJARAT KIDNEY N SUP SP L Share Price Live and GUJARAT KIDNEY N SUP SP L Stock Analysis, the value of tracking through Univest is that today’s price rise can be viewed alongside financial ratios such as P/E, P/B, ROE and ROCE rather than only through headline movement. That makes it easier to connect Price Action with Financial Analysis and sector context.

Frequently Asked Questions

Why is GUJARAT KIDNEY N SUP SP L Share Price rising today?

Ans. GUJARAT KIDNEY N SUP SP L Share Price rose 9% to Rs 148.95 from Rs 136.65. The supplied data confirms the price event and shows active turnover of Rs 4.3 crore, but it does not establish a company-specific catalyst.

What is GUJARAT KIDNEY N SUP SP L Share Price Today?

Ans. GUJARAT KIDNEY N SUP SP L Share Price Today is Rs 148.95. The stock gained 9% in the session versus the previous close of Rs 136.65 and traded between Rs 133.4 and Rs 149.75 during the day.

How much did the stock gain in today’s session?

Ans. The stock gained Rs 12.3 in absolute terms and 9% in percentage terms. That move was enough to place it among today’s top gainers within the screen tracking qualifying price rises by market-cap category.

What was the day’s trading range for GUJARAT KIDNEY N SUP SP L?

Ans. The stock opened at Rs 136.7, touched a day low of Rs 133.4 and a day high of Rs 149.75. This range shows the session included early weakness before the price recovered strongly into higher levels.

Why is this move important for a Small Cap stock?

Ans.< Since the stock’s dayChangePercent was 9, it cleared the required bar for inclusion in this price rise screen.